BSX Q2 2023 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3.6B+10.9% YoY

Gross Profit

$2.3B63.2% margin

Operating Income

$551M15.3% margin

Net Income

$270M7.5% margin

EPS (Diluted)

$0.18

QoQ Revenue Growth

+6.2%

Cash Flow

Operating Cash Flow

$658M

Free Cash Flow

$452M

Stock-Based Comp.

$60M

Balance Sheet

Total Assets

$33.6B

Total Liabilities

$15.1B

Stockholders' Equity

$18.2B

Cash & Equivalents

$426M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.6B	$3.2B	+10.9%
Gross Profit	$2.3B	$2.0B	+14.5%
Operating Income	$551M	$477M	+15.5%
Net Income	$270M	$260M	+3.8%

Revenue Segments

Cardiovascular

$2.2B62%

MedSurg

$1.4B38%

Geographic Segments

UNITED STATES

$2.1B59%

Non-US

$1.5B41%